The mammalian cell culture market size reached USD 1.90 Billion in 2021 and is expected to register a revenue CAGR of 12.13% during the forecast period, according to latest analysis by Emergen Research.

The Global Mammalian cell culture Market report, released by Emergen research, provides the target audience with the key information pertaining to the global Mammalian cell culture Market industry. The research contains the details about the latest events in the Mammalian cell culture market including but not limited to the product launches, acquisition and mergers, collaborations and technology advancements with an aim to help business evangelists, product owners and marketing personnel understand what the future demands, customer preferences, consumption volume, production capacity and supply chain management of the Mammalian cell culture market will be like.

 

 

Mammalian cell cultures are widely used for production of a wide range of biopharmaceutical products including vaccines, monoclonal antibodies, recombinant proteins, and hormones. Rising prevalence of the coronavirus disease has resulted in increased production of vaccines and monoclonal antibodies against the virus, which are produced on mammalian cell culture systems. For instance, the ChAdOX1-nCOV adenovirus vector vaccine is produced in Human Embryonic Kidney (HEK293) cells, while the tocilizumab monoclonal antibody (mAb), which is actively used for treatment of COVID patients is prepared in Chinese Hamster Ovary (CHO) cells. Increasing cases of viral infections, such as mumps and rubella and recent outbreak of measles in several regions in developing countries, is projected to further support revenue growth of the market between 2022 and 2030.

To gain useful market insights, grab a sample copy of this report: https://www.emergenresearch.com/request-sample/1042

Mammalian cell lines are also used for production of therapeutic recombinant proteins against genetic and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. MOR103mAb, which is a human IgG antibody targeted against colony-stimulating factor and causes the diseases, is under active clinical development. MAbs against other autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, as well as against cancer, asthma, and tuberculosis are being developed using mammalian cell lines. This is projected to boost revenue growth of the market between 2022 and 2030.

However, concerns regarding contamination of mammalian cell lines by biological contaminants such as bacteria, yeast, mycoplasma, and viruses and chemicals such as endotoxins is a key factor expected to hamper market revenue growth to some extent. Mammalian cell cultures are shear sensitive, and hence cannot tolerate mechanical agitation, as in case of bacterial cell lines. This is limiting scale-up opportunities for bioprocessing of mammalian cell-based products. In addition, high cost and stringent regulations are some other factors expected to restrain market revenue growth.

Some Key Highlights From the Report

  • Classical media segment revenue is expected to account for largest revenue share during the forecast period, due to low cost, ease of availability, standardized quantification of media ingredients, and the variety of cell lines that can be cultured on the media.
  • C6 segment is expected to register steady revenue CAGR between 2022 and 2030, due to increasing adoption of the cell line for production of commercially important therapeutic proteins and vaccines, including monoclonal antibodies against rheumatoid arthritis. Large-scale production of immunoglobulins and other proteins is also boosting market revenue growth.
  • Europe is expected to account for a relatively larger revenue share in the mammalian cell culture market during the forecast period. Development of bioprocessing techniques with increased opportunities for scaling up of mammalian cell culture systems is a major factor driving revenue growth of the market in Europe. In addition, increasing number of clinical and pre-clinical trials being conducted in countries in this region is another factor contributing to market revenue growth.
  • Some major companies in the global market report include Merck KGaA, ThermoFisher Scientific Inc., Cytiva, Novartis AG, FUJIFILM Irvine Scientific, Agilent Technologies, Inc., Lonza Group AG, GE Healthcare, PromoCell GmbH, and Horizon Discovery Ltd.
  • On 05 April 2022, GE Healthcare of the General Electric Company announced its entry into a Memorandum of Understanding (MoU) with Seoul National University Bundang Hospital (SNUBH) in South Korea aiming to support and boost start-ups in South Korea and the design and implementation of clinical and operational applications. This MoU is expected to set forth an exploration of GE Healthcare’s Edison Digital Health Platform and related services by SNUBH. This will be the first time that the Edison Digital Health Platform has been fully deployed for developers in Korea. The platform is GE Healthcare\'s application hosting and development platform, which provides a range of healthcare-specific services that enable quick application design, development, and deployment.

To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/mammalian-cell-culture-market

Emergen Research has segmented the global mammalian cell culture market on the basis of media, cell line, application, end-use, and region:

  • Media Outlook (Revenue, USD Billion, 2019–2030)
    • Classical Media
    • Serum-Free Media
    • Others
  • Cell Line Outlook (Revenue, USD Billion, 2019–2030)
    • CHO
    • WI-38
    • C6
    • HEK293
    • HeLa
    • Others
  • Application Outlook (Revenue, USD Billion, 2019–2030)
    • Vaccines
    • Monoclonal Antibodies
    • Tissue Engineering
    • Recombinant Cell Therapeutic Proteins
    • Cytotoxic Testing
    • Others
  • End-Use Outlook (Revenue, USD Billion, 2019–2030)
    • Biopharmaceutical Industry
    • Academic and Research Laboratories
    • Drug Test Laboratories
    • Others
  • Regional Outlook: (Revenue, USD Billion; 2018-2028)
  • North America (U.S.) (Canada) (Mexico)
  • Europe (Germany) (UK) (France) (BENELUX) (Rest of Europe)
  • Asia Pacific (China) (Japan) (South Korea) (Rest of APAC)
  • Latin America(Brazil) (Rest of LATAM)

Get Discount on the Latest Report of UAS Traffic Management System Market : https://www.emergenresearch.com/request-discount/1042

Table of Contents:

Chapter 1 includes an introduction of the global Mammalian Cell Culture Market, along with a comprehensive market overview, market scope, product offerings, and an investigation of the market drivers, growth opportunities, risks, restraints, and other vital factors.

Chapter 2 offers an in-depth analysis of the key manufacturers engaged in this business vertical, along with their sales and revenue estimations.

Chapter 3 elaborates on the highly competitive terrain of the market, highlighting the key manufacturers and vendors.

In Chapter 4, our team has fragmented the Mammalian Cell Culture market on the basis of regions, underscoring the sales, revenue, and market share of each region over the forecast timeline.

Chapters 5 and 6 have laid emphasis on the Mammalian Cell Culture market segmentation based on product type and application

Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs.

Take a Look at our other Reports:

electrophoresis market   https://www.google.com.bh/url?q=https://www.emergenresearch.com/industry-report/electrophoresis-market

 

slide stainers market      https://www.google.com.bh/url?q=https://www.emergenresearch.com/industry-report/slide-stainers-market

 

titanium nitride coating market    https://www.google.com.bh/url?q=https://www.emergenresearch.com/industry-report/titanium-nitride-coating-market

 

managed dns service market       https://www.google.com.bh/url?q=https://www.emergenresearch.com/industry-report/managed-dns-service-market

 

big data as a service market       https://www.google.com.bh/url?q=https://www.emergenresearch.com/industry-report/big-data-as-a-service-market

 

blood collection market   https://www.google.com.bh/url?q=https://www.emergenresearch.com/industry-report/blood-collection-market

 

polyvinylidene fluoride market     https://www.google.com.bh/url?q=https://www.emergenresearch.com/industry-report/polyvinylidene-fluoride-market

 

smart speaker market    https://www.google.com.bh/url?q=https://www.emergenresearch.com/industry-report/smart-speaker-market

                       

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services